Therapeutics, Lululemon, RH are among the stocks that made changes
Bristol Myers Squibb has agreed to buy biopharmaceutical company Turning Point Therapeutics for $4.1 billion. Lululemon shares rose 1% in premarket trading after the athletic apparel maker reported a better-than-expected quarter. CrowdStrike (CRWD) – CrowdStrike fell 4.3% in premarket activity despite the fact that the network safety organization posted surprisingly good outcomes for its most … Read more
